ストックスクリーナーアプリを入手
34.05
0.12%
-0.04
アフターアワーズ：
34.05
前日終値:
$34.09
開ける：
$34
24時間の取引高:
527.94K
Relative Volume:
0.77
時価総額：
$1.74B
収益：
$681.88M
当期純損益:
$122.63M
株価収益率:
16.14
EPS:
2.11
ネットキャッシュフロー:
$220.18M
1週間 パフォーマンス:
+12.30%
1か月 パフォーマンス:
+17.13%
6か月 パフォーマンス:
-5.63%
1年 パフォーマンス:
+8.86%
1日の値動き範囲:
$33.70
$34.50
1週間の範囲:
$29.82
$34.50
52週間の値動き範囲:
$26.47
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
名前
Harmony Biosciences Holdings Inc
セクター
電話
(484) 539-9800
住所
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
HRMY を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.05 | 1.74B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2024-10-10 | 再開されました | Raymond James | Outperform |
| 2024-09-10 | 開始されました | UBS | Buy |
| 2024-06-21 | 開始されました | Citigroup | Buy |
| 2024-01-02 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-25 | ダウングレード | Goldman | Neutral → Sell |
| 2023-09-07 | 開始されました | Berenberg | Buy |
| 2023-04-20 | 開始されました | BofA Securities | Neutral |
| 2022-10-14 | アップグレード | Janney | Neutral → Buy |
| 2022-10-14 | アップグレード | Jefferies | Hold → Buy |
| 2022-08-03 | ダウングレード | Jefferies | Buy → Hold |
| 2022-07-13 | ダウングレード | Goldman | Buy → Neutral |
| 2022-07-07 | 開始されました | Mizuho | Buy |
| 2022-04-14 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-12-01 | 開始されました | Oppenheimer | Outperform |
| 2021-11-04 | 開始されました | Raymond James | Outperform |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-03-29 | アップグレード | Goldman | Neutral → Buy |
| 2020-09-14 | 開始されました | Goldman | Neutral |
| 2020-09-14 | 開始されました | Jefferies | Buy |
| 2020-09-14 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Harmony Biosciences Holdings Inc (HRMY) 最新ニュース
Investors who lost money on Harmony Biosciences Holdings, Inc. should contact Levi & Korsinsky about an ongoing investigationHRMY - ACCESS Newswire
Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2025 Earnings Call Transcript - Insider Monkey
Harmony Biosciences Holdings First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Harmony Biosciences (HRMY) Maintains "Buy" Rating with $49 Price Target | HRMY Stock News - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Call Hi - GuruFocus
Decoding Harmony Biosciences Holdings Inc (HRMY): A Strategic SW - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Results - TipRanks
Harmony Biosciences Reports Strong Earnings and Growth - TipRanks
Harmony Biosciences Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:HRMY) - Seeking Alpha
Harmony Biosciences reports Q1 EPS $1.03, consensus 91c - TipRanks
Harmony Biosciences Q1 2025 Earnings Call Transcript - MarketBeat
Harmony (HRMY) Reports Increase in Cash and Investments | HRMY S - GuruFocus
Harmony Biosciences (HRMY) Receives Buy Rating Reiteration by Ne - GuruFocus
Harmony Biosciences Q1 Adjusted Earnings, Revenue Increase; 2025 Sales Outlook Reiterated - marketscreener.com
Deep Dive Into Harmony Biosciences Hldgs Stock: Analyst Perspectives (13 Ratings) - Benzinga
Harmony Biosciences Holdings, Inc. (HRMY) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance
Harmony Biosciences Q1 2025 Earnings: EPS of $0.78 and Revenue o - GuruFocus
Harmony Biosciences Holdings, Inc. SEC 10-Q Report - TradingView
Harmony Biosciences (HRMY) Reports Q1 Revenue Surpassing Expectations | HRMY Stock News - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Hi - GuruFocus
Harmony Biosciences Holdings, Inc Q1 Profit Increases, Beats Estimates - Nasdaq
Harmony Biosciences stock surges 5% on strong Q1 earnings beat By Investing.com - Investing.com Canada
Harmony Biosciences stock surges 5% on strong Q1 earnings beat - Investing.com Australia
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance ? | HRMY Stock News - GuruFocus
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance - marketscreener.com
Earnings Flash (HRMY) Harmony Biosciences Holdings Reports Q1 Adjusted EPS $1.03 - marketscreener.com
Harmony Biosciences Reports Strong Q1 2025 Financial Results, Highlights Advancement of Its Pipeline and Upcoming Catalysts, and Reaffirms 2025 Revenue Guidance - Business Wire
Harmony Biosciences to Report First Quarter 2025 Financial Resul - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) Q1 2025 Earnings Report Preview: What to Look For - GuruFocus
Raymond James Financial Inc. Makes New $1.30 Million Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Wells Fargo & Company MN Reduces Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Harmony Biosciences Holdings Inc expected to post earnings of 59 cents a shareEarnings Preview - TradingView
(HRMY) Trading Signals - news.stocktradersdaily.com
HC Wainwright Has Negative Outlook for HRMY Q1 Earnings - Defense World
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Rating of “Buy” from Analysts - Defense World
Why Harmony Biosciences (HRMY) Could Beat Earnings Estimates Again - Yahoo Finance
H.C. Wainwright maintains $70 target on Harmony Biosciences stock By Investing.com - Investing.com India
Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025 - BioSpace
H.C. Wainwright maintains $70 target on Harmony Biosciences stock - Investing.com Australia
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
UBS Adjusts Price Target for Harmony Biosciences (HRMY) | HRMY S - GuruFocus
UBS Adjusts Price Target on Harmony Biosciences to $48 From $55, Maintains Buy Rating - marketscreener.com
Envestnet Asset Management Inc. Purchases 1,321 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Harmony Biosciences (HRMY) Projected to Post Earnings on Tuesday - Defense World
First Week of June 20th Options Trading For Harmony Biosciences Holdings (HRMY) - Nasdaq
Is Weakness In Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - simplywall.st
BofA Cuts Price Target on Harmony Biosciences to $32 From $33 - marketscreener.com
Harmony Biosciences (HRMY) Faces Revised Price Target Amid Q1 Ch - GuruFocus
Harmony Biosciences Holdings Inc (HRMY) 財務データ
収益
当期純利益
現金流量
EPS
0.84%
0.15%
大文字化:
|
ボリューム (24 時間):